|
HS Code |
815963 |
| Chemicalname | 2-Piperazinonicotinonitrile |
| Molecularformula | C10H12N4 |
| Molecularweight | 188.23 g/mol |
| Casnumber | 119193-13-2 |
| Appearance | White to off-white solid |
| Meltingpoint | 140-143 °C |
| Solubility | Soluble in DMSO and methanol |
| Purity | Typically >98% |
| Storage | Store at 2-8°C, dry place |
| Synonyms | 2-(N-piperazinyl)nicotinonitrile |
| Smiles | C1CN(CCN1)C2=NC=CC(=C2)C#N |
| Inchikey | ZZKCKFWAPNRVOI-UHFFFAOYSA-N |
As an accredited 2-Piperazinonicotinonitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 2-Piperazinonicotinonitrile arrives in a sealed, amber glass bottle containing 25 grams, labeled with hazard and handling instructions. |
| Shipping | 2-Piperazinonicotinonitrile is shipped in tightly sealed containers, protected from moisture and light, and labeled in accordance with chemical safety regulations. Packaging conforms to local and international transport standards for hazardous materials. Appropriate documentation, including safety data sheets, accompanies each shipment. Handling and transport are managed by trained personnel to ensure safety and compliance. |
| Storage | 2-Piperazinonicotinonitrile should be stored in a tightly closed container, in a cool, dry, and well-ventilated area. Keep it away from sources of ignition, heat, and incompatible materials such as strong oxidizing agents. Avoid prolonged exposure to air and moisture. Proper labeling and secondary containment are recommended to prevent leaks or spills. Store according to local chemical regulations and safety guidelines. |
Applications of 2-Piperazinonicotinonitrile in Industrial ManufacturingAs a specialized manufacturer of 2-Piperazinonicotinonitrile, we supply high-purity batches for critical applications in pharmaceutical synthesis, agrochemical intermediates, advanced specialty chemicals, and research reagents. The following sections outline real industrial use scenarios, highlighting relevant regulatory frameworks, formulation ratios, process incorporation details, and end-product types based on our direct customer collaboration and production experience. 1. Pharmaceutical Intermediate for Antipsychotic APIs2-Piperazinonicotinonitrile serves as a key synthetic intermediate in the multi-stage preparation of atypical antipsychotic active pharmaceutical ingredients such as aripiprazole and its analogues. Pharmaceutical manufacturers introduce our material at the piperazine derivatization step, where it reacts with substituted halonitrobenzenes to build the core heterocycle essential for further functionalization. Success in this application requires strict adherence to ICH Q7 GMP protocols and full traceability for regulatory filings. The amount included per batch depends on scale-up balance with reactant equivalents and desired yield optimization during upstream and downstream phase-appropriate development. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate for Pyridine-based PesticidesOur 2-Piperazinonicotinonitrile supports crop protection companies as a backbone precursor to a class of pyridine-derived insecticides and herbicides. The compound enters production at the heterocycle assembly stage, where it undergoes acylation or alkylation, enabling efficient construction of bioactive frameworks for final formulation. Strict observance of REACH and FAO/WHO specifications governs its use in these regulated applications, especially in pre-registration and quality audits for global export markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Building Block for Specialty Chemical Synthesis in Advanced MaterialsProducers of specialty polymers and electronic chemicals utilize our material for the synthesis of tailored heterocyclic linkers that enhance thermal stability and electronic performance in final products. 2-Piperazinonicotinonitrile reacts during the monomer design phase, acting as a privileged scaffold for functional monomers in specialty polyimides and PEEK analogues. Processing requires conformance to ISO technical norms and internal quality management, especially for hi-rel electronics and engineering plastics industries. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research Chemical for Drug Discovery and Library SynthesisChemical research organizations and contract research labs procure our high-purity material for diversified heterocycle library synthesis, lead optimization, and new molecular entity (NME) construction. The compound supports medicinal chemistry exploration by enabling efficient access to a broad range of piperazine-decorated analogues. Researchers follow GLP or R&D best practice standards depending on project phase, and flexibly vary input ratios based on screening needs and compound library design. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-Piperazinonicotinonitrile prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Over the past decade, the demand for advanced intermediates like 2-piperazinonicotinonitrile has grown in both scale and complexity. In the years spent handling its production lines, we have learned that developing reliable processes cuts deeper than installing reactors and drawing flow diagrams. Chemical plants need more than textbook answers; stable sourcing, process adaptability, and clear differentiation from similar intermediates shape every decision on our shop floor.
2-Piperazinonicotinonitrile, known among chemists by its CAS number 94313-16-5, arose from targeted medicinal chemistry and agricultural R&D programs. Pharmaceutical and agrochemical innovators lean on it as a key intermediate because of how its piperazine and pyridine structures combine. On the ground, its real value reveals itself in scalable synthesis pathways, low impurity profiles, and how reliably it integrates with upstream and downstream processes.
Nothing in chemical manufacturing advances without deliberate design and years of trouble-shooting. For 2-piperazinonicotinonitrile, the method and technology behind every batch determine real-world outcomes for our downstream partners. Over multiple process revamps, we shifted from labware to full-scale jacketed reactors controlled with precise temperature gradients and pressure monitoring. Each time we scaled up, we faced new challenges: foam development mid-run, exotherms during cyclization, reactor fouling, and filtration issues with certain byproducts.
Achieving industrial-grade product takes vigilance—not only at the endpoint, but at every handoff. Purity matters, but so does the way we manage mother liquor recycling, batch consistency, and solubility habits on scale-up. Each set of customers—from pharma process chemists to agricultural R&D leads—asks for a material that arrives with tight specs and clear documentation. Responding to these needs, we put our focus on two fronts: process yield and impurity control. Our attention goes into in-process analytics, rigorous drying methodology, and full lot traceability.
Our standard offering comes as a white to off-white crystalline powder. This form travels well in lined drums and withstands moderate humidity swings in transit. We control water content via vacuum drying, performing Karl Fischer titrations batchwise and confirming residual solvent levels on every lot. Typical purity levels exceed 99 percent (by HPLC), but customers working up through regulatory submissions often push for extra-low NMTs (Not More than) on process residues—especially following ICH Q3 guidelines.
Chemists in development labs sometimes mention sample bottles “looking the same.” In our plant, identical appearance does not always reflect identical chemistry. We routinely analyze for piperazine ring opening, pyridine N-oxidation, and structurally similar side products unique to our route. Years back, a minor impurity started eluting in trace amount on stability after three months at elevated temperature. The learning there led to tweaks in crystallization and a revised antioxidant addition on workup. Small changes, like adjusting sodium carbonate equivalents or solvent switches, drive down unwanted signal and keep outputs true to published structure.
The questions most often raised by technical customers focus on distinctions between 2-piperazinonicotinonitrile and its chemical siblings. Compounds sharing the same piperazine scaffold, or those based on nicotinonitrile without the bis-nitrogen ring, make for interesting swap-out experiments in drug development or agro R&D. On the manufacturing side, we track differences that rarely get mentioned in reference data sheets.
For instance, straight nicotinonitrile (no piperazine moiety) lays open to nucleophilic substitution but reacts differently under hydrogenation. Piperazine derivative intermediates—with methyl, chloro, or carboxy substitutions—show marked changes in solubility in common solvents. Where some crystallize out clean under standard cooling, others demand anti-solvent or seeded protocols. Our experience with 2-piperazinonicotinonitrile puts it in a spot between high reactivity (helpful for quick coupling) and chemical stability (essential for shelf life and transport).
Working with piperazine derivatives, the tendency for certain ring-closed forms to revert or dimerize affects percent yield and process trouble-shooting. Some analogs, especially mono-substituted varieties, have higher rates of side reactions during workup. By comparison, our product maintains strong ring integrity through extended operations and does not collapse under most standard conditions. This makes it dependable for both lab and industrial-scale utilization.
We see 2-piperazinonicotinonitrile go out the door for more than pilot batches and paper studies. Its use spreads across contract pharma, crop science, and chemical biology. In customer feedback meetings, the standout features are its adaptability to modifications (for example, N-alkylation or N-acylation processes), low baseline impurity, and consistent performance in scale reactions. Chemical developers appreciate less time spent on “purification headaches” and more on meeting regulatory proof demands.
Actual projects have ranged from scalable syntheses of experimental CNS-active compounds to crop protection molecule building blocks. Speed matters in these settings. We field urgent sample requests for fast iterative development cycles, then manage routine kilogram-scale orders once projects advance. No two programs are exactly alike, but they do share a need for clean starting points, detailed CoA (certificate of analysis) data, and clear impurity profiles.
In research alliances, partners have fed back about how a strong supply of such intermediates cuts down risk when scaling lead candidates. Early bottlenecks—like formulation issues linked to wet cake residue or side-chain cross-contamination—get minimized by keeping supply chain touchpoints inside a single controlled plant workflow. We respond to these with real adjustments to material handling: double-lining, pre-desiccation shipments, and year-round monitoring against humidity spikes in warehouse storage areas.
Being involved from synthesis to dispatch and follow-up gives us a broader picture than the numbers on a product sheet. It lets us share lessons directly from site experience, not a repackaging warehouse. Raw material choice, especially on piperazine and pyridine stocks, shapes every run’s profile. Purity isn’t only a reading on the final CoA—it comes from regular solvent checks, raw material screening, and operator-level attention to variance.
At one stage, price pressures drove a segment of the sector toward alternate synthetic routes. Too often, cutting corners on raw feed led to more frequent failure at scale, or long-term supply chain snags. We never made that trade-off. A batch gone wrong can take days, not hours, to diagnose and clear. Full pre-run checks, real endpoint analytics, and direct operator accountability make consistent high-quality batches routine rather than exceptional.
Safety weighs into each production decision. Piperazine intermediates can aerosolize or emit strong odors during specific steps. We operate with full containment during transfer and blend, using engineered venting and scrubbers to address every point of possible emissions. Our operators take direct responsibility, from valve settings to sample draws, guided by decades of hands-on chemical production experience. Finished goods leave in sealed HDPE barrels or lined fiber drums, double-checked for tight sealing and labeled with date and batch trace codes.
Operations never stand still. The plant environment throws curveballs with aging equipment, changing raw inputs, or seasonal humidity shifts. For 2-piperazinonicotinonitrile, we view every campaign as an opportunity for process tuning. Recently, introducing advanced agitation and in-line temperature monitoring carved out marked improvements in both batch yield and impurity limits. Where once a run finished with NMT 0.5 percent total organic impurities, we have pulled that below 0.2 percent on back-to-back lots. Small changes, like drum closure checks and more sensitive leak detection sensors, catch product-handling concerns before they build into logistical headaches.
Technical inspection doesn’t end with internal audits. Our customers run their own checks and supply feedback data. This multi-check system keeps us honest as manufacturers—less room for error, more reward for consistency. It shapes an environment where we notice trends in customer returns, logistics bottlenecks, or spec drift long before a pattern can build into a big issue. Over time, trust builds not from a single delivery, but from an extended track record without incident.
Regulatory frameworks impose strict requirements on intermediates feeding into medicines and advanced chemicals. At our facility, we align documentation with international quality authorities. Good Manufacturing Practices (GMP) principles inform lot traceability, cleanliness of equipment, handling of cleaning validation, and operator training. Each batch produced receives full origin and process documentation, including raw data from analytical runs. The drive toward compliance strengthens batch-to-batch reproducibility and transparency with technical partners.
We do not blind-ship for third parties or break bulk without a documented chain of custody. This prevents grey-market dilution and keeps actionable accountability attached to every lot leaving our facility. Some markets seek audit clearance and on-site supply chain documentation for their confidential projects; we host those reviews with direct plant access, unfiltered by sales offices or third-party resellers.
The realities of shipping chemicals stretch from container selection to timing and transit risk. Early years saw us pack 2-piperazinonicotinonitrile in several drum types, evaluating dust potential, moisture pickup, and stack stability. Flexible liners prevent cross-contamination and ease drum unloading at the destination. Inspections before palletization guard against lid loosening and tear-throughs along the drum seam during loading. This might sound granular, but small changes—like tightening seal protocols and on-site photography of finished pallets—deflate many of the causes of transit complaints before departure.
Global movement brings customs inspection, dockside weather issues, and occasionally prolonged storage at external depots. Our product does not degrade easily outdoors for short periods, but pallets remain wrapped and stacked under canopies during loading at port. In the rare events of delay, the drums open with unchanged test profiles upon arrival—a key advantage of focusing on low residual solvent and regulated moisture level at fill stage.
Buyers in the chemical market watch for consistency, not just competitive price. Projects on clinical timelines or with regulatory submissions cannot wait for an uncertain or variable supply. We balance regular output with project-based collaboration. Some clients trigger rolling releases or multi-lot blanket orders to sidestep supply disruptions. For those moving from bench to pilot to plant, we provide graduated batch sizes along stepped project phases. This practical, ground-up approach lets customers manage validation, regulatory submission, and process switching with one supply source.
Experienced buyers ask for documented impurity profiles and analytical trends, not only end-point numbers. We deliver trend sheets if requested, showing the backbone of process reliability—actual impurity progression over time, occasional blips linked to process tweaks or raw input changes, and full explanations where any drift occurred.
If custom modification is needed, we tackle those as site projects, bringing research chemists and production managers together to agree on changes before moving into commercial output. This keeps both quality and delivery predictable for innovators pushing their own products to market or regulatory submission.
Supplying intermediates is not simply a matter of running a reactor, drying material, and sending a clean bill of lading. Over the years, genuine partnerships have taught us that transparency—shared method improvements, impurity management discussions, and real effort invested in understanding end-use—delivers results far above what a catalog transaction ever could. Site visits, process technical sessions, and regular feedback reviews allow solutions to emerge before questions escalate into supply chain interruption.
Technical users benefit from real feedback loops. Issues like solubility, melting range adjustment, or atypical side product emergence form recurring touch points between our teams and theirs. Tackling such hurdles together forces both sides to invest in robust process capability. We integrate improvements gleaned from customer pilot data, not just internal retrospectives. If a medical or agro client flags a problem in intermediate coupling, our chemists investigate root causes and feed answers back, implementing process adjustment before bottleneck turns into lost project time.
The push toward greener manufacturing blends into both equipment selection and raw input choices. For 2-piperazinonicotinonitrile, waste minimization starts with route design. Working with atom-economical approaches and solvent recycling loops, we bring both cost and environmental footprints down to levels demanded by accountable modern manufacturing. Utilities draw from energy recovery units, lighting relies on smart sensors, and waste is segregated for proper downstream processing.
Customers and regulators alike watch for responsible sourcing: not just “where did it come from,” but how was it manufactured? How does the finished intermediate align with sustainability benchmarks—waste reduction, emissions, and energy consumption? We keep those metrics not only for internal reporting, but also as part of our continuous improvement and customer transparency commitment.
Producing 2-piperazinonicotinonitrile means more than just delivering an intermediate to a waiting dock. Behind every drum stands a history of daily decisions—route improvement, purity strategy, logistics planning, real engagement with technical buyers, and strong site safety controls. Chemical manufacturing rewards those who pay attention to detail, stay open to technical dialogue, and answer not only today’s needs but those of tomorrow’s project timelines. The process does not rest on routine or shortcut. Only through hands-on improvement and real engagement between producer and customer does a product like this continue to meet both the letter and spirit of modern industry standards.